1H-BENZIMIDAZOLE-1-CARBOXYLIC ACID, 4-(BROMOMETHYL)-6-CHLORO-, 1,1-DIMETHYLETHYL ESTER, 95%, 100mg

ETHYL 2-METHYL-8-PHENYLMETHOXYIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE, 95.0%, 5g

Condenseur d'Abbe 1,25 NA avec ouverture pour champ sombre et lame à contraste de phase. Sans lame à fond noir et sans lame à contraste de phase

[1-(4-ethylphenyl)ethyl]amine hydrochloride, 95.0%, 1g

Sodium 3-(allyloxy)-2-hydroxypropane-1-sulfonate (40 wt. % in H2O), 95.0%, 25g

Methylacetylsalicylate, 98.0%, 10g

1H-Imidazol-2-ylmethanol, 95.0%, 100mg

Pyridin-2-yl(thiazol-2-yl)methanone, 95.0%, 1g

2-Amino-3,5,6-trifluorobenzoic acid, 95+%, 250mg

(1R,2S)-rel-Cyclopropane-1,2-dicarboxylic acid, 95.0%, 10g

(2,6-Bis(trifluoromethyl)phenyl)boronic acid, 98%, 5g

Ethyl 4-((6-guanidinohexanoyl)oxy)benzoate methanesulfonate, 98%, 5g

2-Chloro-6-methylpyridin-4-amine, 97.0%, 250mg